This inventor holds 5 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Assistance Publique - Hopitaux De Paris (Aphp), Centre National De La Recherche Scientifique. Active years: 2014-2021.
Location History:
- Paris, FR (2016)
- Sevran, FR (2014 - 2021)
Company Filing History:
5 out of 1,853 
1 out of 77 
1 out of 5,383 
Years Active: 2014-2021
Title: Giovanni Stevanin: Innovator in Motor Neuron Diseases
Introduction
Giovanni Stevanin, an accomplished inventor based in Sevran, France, has made significant contributions to the field of medical research, particularly in the treatment of motor neuron diseases. With five patents to his name, his work has the potential to enhance the understanding and treatment options available for hereditary spastic paraplegias (HSP).
Latest Patents
Stevanin's latest inventions include groundbreaking patents focused on inhibitors of gangliosides metabolism for the treatment of motor neuron diseases. This innovative approach targets the harmful effects associated with gangliosides, which play a role in various neurological disorders. Additionally, he has developed a diagnostic method for hereditary spastic paraplegias that involves the detection of mutations in the KIAA1840 gene or protein (known as spatacsin). This ex vivo method facilitates the diagnosis or prediction of HSP in subjects, representing a significant advancement in the genetic understanding of this condition.
Career Highlights
Throughout his career, Giovanni Stevanin has been affiliated with prominent institutions such as the Institut National de la Santé et de la Recherche Médicale and the Institut du Cerveau et de la Moelle Épinière (ICM). His tenure at these research organizations underscores his dedication to advancing healthcare and improving the lives of individuals affected by motor neuron diseases.
Collaborations
Stevanin has collaborated with esteemed colleagues in the field, including Alexis Brice and Hamid Azzedine. Their collective expertise and efforts have contributed to the development of pioneering research that aims to provide better diagnostic and therapeutic strategies for motor neuron diseases.
Conclusion
Giovanni Stevanin's innovative work and patent portfolio signify his commitment to addressing pressing challenges in neurology. His inventions not only pave the way for new treatment avenues but also enhance our understanding of the genetic factors involved in hereditary spastic paraplegias. As research continues to evolve in this field, Stevanin's contributions will undoubtedly play a crucial role in shaping future advancements.